phenytoin will decrease the level or effect of fentanyl by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Coadministration of fentanyl with CYP3A4 inducers could lead into a lessen in fentanyl plasma concentrations, deficiency of efficacy or, possibly, progress of a withdrawal syndrome in a very patie
ritlecitinib will increase the level or effect of fentanyl by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Ritlecitinib inhibits CYP3A4 substrates; coadministration will increase AUC and peak plasma concentration sensitive substrates, which may increase risk of adverse reactions.The need curve for fentanyl w
bosentan will reduce the level or effect of fentanyl by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Carefully. Coadministration of fentanyl with CYP3A4 inducers could lead on to a minimize in fentanyl plasma concentrations, not enough efficacy or, possibly, progress of a withdrawal syndrome in a affected person that